SCHEMBL2195181

SCHEMBL2195181

CN(C)C(=O)CC(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375600 0.79 ALDH1A1 (0.41) —
SCHEMBL801270 0.74 — —
SCHEMBL1615800 0.72 CHRNB2 (0.58) —
SCHEMBL18461960 0.72 — —
SCHEMBL3909951 0.72 — —
SCHEMBL19910614 0.72 — —
SCHEMBL1615790 0.72 — —
SCHEMBL3907850 0.72 — —
SCHEMBL3096327 0.72 ALDH1A1 (0.39) —
SCHEMBL11639063 0.72 LMNA (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944752-B2 Block copolymers for stable micelles INTEZYNE TECHNOLOGIES, INC. (US) 2018-04-17 — — US disclosed
US-9944754-B2 Block copolymers for stable micelles INTEZYNE TECHNOLOGIES, INC. (US) 2018-04-17 — — US disclosed
US-20170073341-A1 Benzene Sulfonamide Thiazole and Oxazole Compounds NOVARTIS AG (CH) 2017-03-16 — — US disclosed
EP-3106462-A1 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS Novartis AG (CH) 2016-12-21 — — EP disclosed
US-9499665-B2 Block copolymers for stable micelles INTEZYNE TECHNOLOGIES, INC. (US) 2016-11-22 — — US disclosed
US-20160264732-A1 BLOCK COPOLYMERS FOR STABLE MICELLES INTEZYNE TECHNOLOGIES, INC. 2016-09-15 — — US disclosed
EP-2282636-B1 BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS NOVARTIS AG (CH) 2016-03-23 — — EP disclosed
US-20160068523-A1 Benzene Sulfonamide Thiazole and Oxazole Compounds NOVARTIS AG (CH) 2016-03-10 — — US disclosed
US-9233956-B2 Benzene sulfonamide thiazole and oxazole compounds NOVARTIS AG (CH) 2016-01-12 — — US disclosed
US-20150368401-A1 BLOCK COPOLYMERS FOR STABLE MICELLES INTEZYNE TECHNOLOGIES, INC. 2015-12-24 — — US disclosed
US-20050222128-A1 Compounds for the treatment of diseases PFIZER INC 2005-10-06 — — US disclosed
EP-1226146-A2 QUINOLINE AND NAPHTHYRIDINE CARBOXYLIC ACID ANTIBACTERIALS ABBOTT LABORATORIES (US) 2002-07-31 — — EP disclosed
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 — — US disclosed
WO-2001032655-A2 QUINOLINE AND NAPHTHYRIDINE CARBOXYLIC ACID ANTIBACTERIALS ABBOTT LABORATORIES (US) 2001-05-10 — — WO disclosed
EP-0628561-B1 Process for preparing cephalosporin compounds from reactive organic acid derivatives LUCKY LTD (KR) 1997-09-03 — — EP disclosed
US-5567813-A Process for preparing cephalosporin compounds from reactive organic acid derivatives LUCKY LTD. (KR) 1996-10-22 — — US disclosed
EP-0628561-A1 Process for preparing cephalosporin compounds from reactive organic acid derivatives LUCKY LTD. (KR) 1994-12-14 — — EP disclosed
US-4311699-A Aminoacid derivatives of cephalosporin compounds HASKELL THEODORE H 1982-01-19 — — US disclosed
US-4267180-A PENICILLINS AND DERIVATIVES WARNER-LAMBERT COMPANY (US) 1981-05-12 — — US disclosed
EP-0015772-A1 N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same WARNER-LAMBERT COMPANY (US) 1980-09-17 — — EP disclosed
Send feedback